US5330520A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable electrode and sensor lead apparatus
Assignee: Pacesetter Inc
•
Filing: 1991-10-08
•
Granted: 1994-07-19
•
Expires: 2011-10-08
Abstract
Abstract A transvenous cardioversion lead system capable of delivering electrical energy to cardiac tissue is provided. Lead system comprises an inner conductor surrounded by an insulative layer which, in turn, is surrounded by a second conductor mounted coaxially with the inner conductor. At least a portion of the second conductor is surrounded by an outer conductive sheath formed from a suitable material having an non-abrasive affect. This prevents damage to cardiac tissue during normal transvenous operating position while at the same time preventing thrombogenesis on the lead surface.
Inventors
- 👤 David S. Maddison
- 👤 Michael Skalsky
- 👤 Gerhard Gotthardt
- 👤 Neil Anderson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 23:37
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61B; A61B18/00; A61B2018/00053; A61B2018/00107
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
102 words
A flexible electrode cardioversion or defibrillation lead for use in a transvenous lead system for supplying electrotherapy to the heart comprising: an inner conductive layer; an insulative layer surrounding said inner conductive layer; an outer conductive layer surrounding said insulative layer; and an outer conductive sheath surrounding at least a portion of said outer conductive layer; wherein said sheath is formed from a flexible, biocompatible material having a non-abrasive effect on cardiac tissue during operation of said lead, said material comprising intrinsically conducting polymers, said material being able to supply a cardioverting/defibrillating energy discharge having a magnitude of up to 40 Joules.
Claim 2
Dependent Claim
102 words
A flexible electrode cardioversion or defibrillation lead for use in a transvenous lead system for supplying electrotherapy to the heart comprising: an inner conductive layer; an insulative layer surrounding said inner conductive layer; an outer conductive layer surrounding said insulative layer; and an outer conductive sheath surrounding at least a portion of said outer conductive layer; wherein said sheath is formed from a flexible, biocompatible material having a non-abrasive effect on cardiac tissue during operation of said lead, said material comprising intrinsically conducting polymers, said material being able to supply a cardioverting/defibrillating energy discharge having a magnitude of up to 40 Joules.
Claim 3
Dependent Claim
35 words
The lead of claim 1, wherein said conducting polymers are selected from the group consisting of polyacetylene, polypyrolle, poly (para-phenylene), poly (para-phenylene sulfide), poly (sulfur nitride) and polymers wherein electrical conductivity is increased by doping.
References Cited (Backward Citations)
US4033357A
Cited
DE2604581A1
Cited
DE2822829A1
Cited
EP0057450A1
Cited
US4352360A
Cited
US4585013A
Cited
US4624261A
Cited
US4784161A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-07-18 | 1998-01-17 | 1998-07-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-07-18 | 2002-01-17 | 2002-07-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-07-18 | 2006-01-17 | 2006-07-19 | $7700.00 | Window Closed / Lapsed |